Haier Biomedical Advances Europe-Focused Strategy with Lab Solutions Showcase at analytica Munich 2026
MUNICH: Haier Biomedical used its platform at analytica Munich 2026 to underline its expanding role as a provider of integrated laboratory solutions, highlighting its “In Europe, For Europe” approach to strengthening regional presence.
The company is positioning itself beyond traditional equipment manufacturing, offering end-to-end laboratory systems that cover the full lifecycle of samples, from collection and storage to monitoring and data management.
Showcasing End-to-End Capabilities
Its exhibition featured a broad range of advanced equipment, including CO₂ incubators, biosafety cabinets, centrifuges, autoclaves, pharmacy refrigeration systems and liquid nitrogen storage units.
New technologies such as incubator shakers and freeze dryers were also introduced, aimed at improving laboratory efficiency and precision.
Innovation Driving Performance Gains
A key highlight was the UltraEco ultra-low temperature freezer series, which incorporates Eco-Drive technology to deliver significantly higher energy efficiency compared to industry norms.
The company also presented integrated biobanking systems designed to automate workflows and enhance both operational efficiency and data traceability.
Expanding Local Footprint in Europe
Haier Biomedical reiterated its localisation strategy, adopting a tailored “one country, one strategy” model across multiple European markets.
With strong local teams and extensive certifications, the company has strengthened its foothold and competitiveness in the region.
Customised Solutions for Regional Needs
Its projects across Europe include supplying biosafety cabinets to Queen Mary University of London, implementing intelligent blood management systems in Italy and delivering advanced cryogenic freezers to research institutions in Germany.
These deployments reflect its focus on addressing specific local requirements.
Transition to Ecosystem-Based Growth
The company said its presence at analytica 2026 signals a broader strategic shift towards building an integrated ecosystem that combines technology, local expertise and partnerships.
Moving forward, Haier Biomedical aims to deepen its European engagement while strengthening its position as a global innovator in life sciences.
-wilayah.com.my
